För att webbplatsen ska fungera på ett bra sätt för dig använder vi nödvändiga kakor. Vi använder också kakor för webbanalys för att förbättra webbplatsen.
The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis , Chapple et al. Eur Urol 2008;54:543
A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder, Novara et al. Eur Urol 2008; 54:740
Superior efficacy of fesoterodine over tolterodine extended release with rapid onset: a prospective, head-to-head, placebo-controlled trial. Kaplan et al. BJU Int 2011; 107:1432
Overactive bladder drugs and constipation: a meta-analysis of randomized, placebo-controlled trials. Meek et al. Dig Dis Sci 2011; 56:7
Systematic review and meta-analysis: do clinical trials testing antimuscarinic agents for overactive bladder adequately measure central nervous system adverse events? Paquette et al. J Am Geriatr Soc 2011; 59:1332
Gray SL, Anderson ML, Dublin S et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med 2015; 175: 401–7
Richardson K, Fox C, Maidment I et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ 2018; 361: k1315
Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia: a nested case-control study. JAMA Intern Med. 2019; 179: 1084
Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Roehrborn et al. Urology 1999; 53:581
Efficacy and safety of tadalafil 5 mg once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: subgroup analyses of pooled data from 4 multinational, randomized, placebo-controlled clinical studies. Porst et al. Urology 2013; 82:667
Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms sug- gestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study. Giuliano et al. J Sex Med 2013; 10:857
Testosterone levels in patients with metastatic prostate cancer treated with luteinizing hormone-releasing hormone therapy: prognostic significance?, Perachino et al. BJU Int 2010 ;105 :648
Redefining Clinically Significant Castration Levels in Patients With Prostate Cancer Receiving Continuous Androgen Deprivation Therapy Morote et al. J Urol 2007;178:1290
